Taken together, these data suggest that CD133+ colon cancer cells are more invasive in the presence of specific cancer-associated fibroblasts, especially CD10+ fibroblasts, and that these cell populations may be promising targets for inhibiting metastasis and tumor recurrence. The gene discussed is PROM1; the disease is colonic neoplasm.